Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY:LH)

261.50 +1.42 (+0.55%)
Official Closing Price Updated: 6:30 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
1 Healthcare Stock to Consider Right Now and 2 That Underwhelm
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
 
Via Benzinga
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
10 Analysts Have This To Say About Labcorp Hldgs
 
Via Benzinga
Labcorp Raises Full Year Guidance After Q2 Earnings Beat Wall Street Expectations: Retail Sees Rally To $330
Via Stocktwits
Topics Earnings
Earnings Scheduled For July 24, 2025
 
Via Benzinga
A Glimpse of Laboratory Corp's Earnings Potential
 
Via Benzinga
LH Q2 Deep Dive: Specialty Testing Growth, Hospital Acquisitions, and Margin Expansion
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit... 
Via StockStory
Labcorp Posts 9.5 Percent Gain in Q2
Via The Motley Fool
Explore the top gainers and losers within the S&P500 index in today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Labcorp (LH) Shares Skyrocket, What You Need To Know
Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) jumped 6.8% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations and raised its... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are moving in today's session
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Why Is Testing Giant Labcorp Stock Surging On Thursday?
Labcorp beat Q2 earnings and revenue estimates and raised full-year guidance, supported by margin expansion and continued acquisition activity. 
Via Benzinga
Labcorp (LH) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
These S&P500 stocks are gapping in today's session
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
Labcorp Holdings Inc (NYSE:LH) Reports Mixed Q2 2025 Earnings with EPS Beat and Revenue Miss
Labcorp (LH) reported mixed Q2 2025 earnings, missing revenue estimates but beating EPS. Shares rose as raised full-year guidance offset concerns. 
Via Chartmill
Labcorp (NYSE:LH) Posts Better-Than-Expected Sales In Q2
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) announced better-than-expected revenue in Q2 CY2025, with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit of $4.35 per share... 
Via StockStory
Labcorp (LH) Reports Earnings Tomorrow: What To Expect
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings this Thursday morning. Here’s what to expect. 
Via StockStory
Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp
From Community Health Systems, Inc.
Via Business Wire
3 Value Stocks with Questionable Fundamentals
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
My Favorite Options Trade For This Week
With markets typically weakening in August and September, now is a strategic time to consider bearish trades like Labcorp Holdings. 
Via Benzinga
How Do Investors Really Feel About Labcorp Hldgs?
 
Via Benzinga
A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Looking back on testing & diagnostics services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers. 
Via StockStory
Demystifying Labcorp Hldgs: Insights From 8 Analyst Reviews
 
Via Benzinga
3 Profitable Stocks Walking a Fine Line
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Topics Malware
2 S&P 500 Stocks with Promising Prospects and 1 to Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences. 
Via Benzinga
Topics Artificial Intelligence
1 Mid-Cap Stock with Exciting Potential and 2 to Turn Down
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapies 
From Predictive Oncology Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.